Top

Published in:

01-10-2015 | Editorial

Computerized decision making in myocardial perfusion SPECT: The new era in nuclear cardiology?

Authors: Elin Trägårdh, MD, PhD, Marcus Carlsson, MD, PhD, Lars Edenbrandt, MD, PhD

Published in: Journal of Nuclear Cardiology | Issue 5/2015

Excerpt

In this issue of the journal, Arsanjani et al.1 investigate if early revascularization can be predicted by automatic integration of clinical data and image data from myocardial perfusion SPECT (MPS). It has previously been shown that a normal or mildly abnormal MPS is associated with a low frequency of referral for coronary revascularization2 and that a normal MPS is associated with a very low annual risk of cardiac death and acute myocardial infarction.3-5 …

Arsanjani R, Dey D, Khachatryan T, Shalev A, Hayes SW, Fish M, et al. Prediction of revascularization after myocardial perfusion SPECT by machine learning in a large population. J Nucl Cardiol 2014. doi:10.1007/s12350-014-0027-x.

Hachamovitch R, Nutter B, Hlatky MA, Shaw LJ, Ridner ML, Dorbala S, et al. Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol 2012;59:462-74.CrossRefPubMed

Metz LD, Beattie M, Hom R, Redberg RF, Grady D, Fleischmann KE. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: A meta-analysis. J Am Coll Cardiol 2007;49:227-37.CrossRefPubMed

Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 2004;11:171-85.CrossRefPubMed

Navare SM, Mather JF, Shaw LJ, Fowler MS, Heller GV. Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: A meta-analysis. J Nucl Cardiol 2004;11:551-61.CrossRefPubMed

Lindahl D, Lanke J, Lundin A, Palmer J, Edenbrandt L. Improved classifications of myocardial bull’s-eye scintigrams with computer-based decision support system. J Nucl Med 1999;40:96-101.PubMed

Guner LA, Karabacak NI, Cakir T, Akdemir OU, Kocaman SA, Cengel A, et al. Comparison of diagnostic performances of three different software packages in detecting coronary artery disease. Eur J Nucl Med Mol Imaging 2010;37:2070-8.CrossRefPubMed

Wolak A, Slomka PJ, Fish MB, Lorenzo S, Acampa W, Berman DS, et al. Quantitative myocardial-perfusion SPECT: Comparison of three state-of-the-art software packages. J Nucl Cardiol 2008;15:27-34.CrossRefPubMed

Svensson A, Akesson L, Edenbrandt L. Quantification of myocardial perfusion defects using three different software packages. Eur J Nucl Med Mol Imaging 2004;31:229-32.CrossRefPubMed

10.

Heden B, Ohlin H, Rittner R, Edenbrandt L. Acute myocardial infarction detected in the 12-lead ECG by artificial neural networks. Circulation 1997;96:1798-802.CrossRefPubMed

11.

Guner LA, Karabacak NI, Akdemir OU, Karagoz PS, Kocaman SA, Cengel A, et al. An open-source framework of neural networks for diagnosis of coronary artery disease from myocardial perfusion SPECT. J Nucl Cardiol 2010;17:405-13.CrossRefPubMed

12.

Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949-3003.CrossRefPubMed

13.

Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-619.CrossRefPubMed

14.

Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-91.CrossRefPubMed

15.

Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-7.CrossRefPubMed

16.

Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J 2011;32:1012-24.CrossRefPubMed

17.

Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2012;126:e354-471.CrossRefPubMed

Title: Computerized decision making in myocardial perfusion SPECT: The new era in nuclear cardiology?
Authors: Elin Trägårdh, MD, PhD
Marcus Carlsson, MD, PhD
Lars Edenbrandt, MD, PhD
Publication date: 01-10-2015
Publisher: Springer US
Published in: Journal of Nuclear Cardiology / Issue 5/2015
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-014-0041-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Computerized decision making in myocardial perfusion SPECT: The new era in nuclear cardiology?

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2015

Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials

Imaging the patient with a new diagnosis of heart failure in the contemporary era

Expanding the Horizons of Nuclear Cardiology: Disease Management

Responsibility for follow-up of abnormal findings in myocardial perfusion imaging: A case-based ethics discussion

Mixture of ischemia and hibernation in a patient with severe diagonal disease: Value of perfusion and metabolic PET imaging

Precision and accuracy of clinical quantification of myocardial blood flow by dynamic PET: A technical perspective

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page